BACKGROUND: Cadmium Zinc Telluride (CZT) SPECT camera technology has the potential to reduce patient's radiation exposure and shorten imaging time. This study evaluated the correlation of low stress tracer dose, rapid CZT SPECT myocardial perfusion imaging (MPI) to coronary angiography in a <200-lbs population to further validate its ability to achieve both goals while preserving diagnostic accuracy. METHODS: All patients who had a low-dose stress (≤15 mCi) Tc-99m sestamibi SPECT MPI study using a CZT camera (GE Discovery NM 530c) with 3- to 5-minute image acquisition over a 2-year period followed by a coronary angiogram within 2 months were included. Patients with a history of coronary revascularization, left ventricular dysfunction, and LBBB or paced rhythms were excluded. Both MPI studies and coronary angiograms were interpreted by blinded readers and coronary artery disease (CAD) was defined as ≥70% stenosis. RESULTS: A total of 71 patients were included with a mean age of 64 years, 55% male, and a BMI of 25.4 kg/m(2) with an average stress dose of 13.3 mCi. Exercise stress was performed in 54% of patients and vasodilator pharmacologic stress in 46%. Sensitivity was 89%, specificity was 66%, and accuracy was 78% for detecting obstructive CAD. CONCLUSIONS: In this group of non-obese patients undergoing low stress dose imaging, high-efficiency CZT SPECT imaging demonstrated a high sensitivity, specificity, and accuracy for detecting obstructive epicardial CAD with a greatly reduced imaging time.
BACKGROUND:Cadmium Zinc Telluride (CZT) SPECT camera technology has the potential to reduce patient's radiation exposure and shorten imaging time. This study evaluated the correlation of low stress tracer dose, rapid CZT SPECT myocardial perfusion imaging (MPI) to coronary angiography in a <200-lbs population to further validate its ability to achieve both goals while preserving diagnostic accuracy. METHODS: All patients who had a low-dose stress (≤15 mCi) Tc-99m sestamibi SPECT MPI study using a CZT camera (GE Discovery NM 530c) with 3- to 5-minute image acquisition over a 2-year period followed by a coronary angiogram within 2 months were included. Patients with a history of coronary revascularization, left ventricular dysfunction, and LBBB or paced rhythms were excluded. Both MPI studies and coronary angiograms were interpreted by blinded readers and coronary artery disease (CAD) was defined as ≥70% stenosis. RESULTS: A total of 71 patients were included with a mean age of 64 years, 55% male, and a BMI of 25.4 kg/m(2) with an average stress dose of 13.3 mCi. Exercise stress was performed in 54% of patients and vasodilator pharmacologic stress in 46%. Sensitivity was 89%, specificity was 66%, and accuracy was 78% for detecting obstructive CAD. CONCLUSIONS: In this group of non-obesepatients undergoing low stress dose imaging, high-efficiency CZT SPECT imaging demonstrated a high sensitivity, specificity, and accuracy for detecting obstructive epicardial CAD with a greatly reduced imaging time.
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: J Nucl Cardiol Date: 2002 Mar-Apr Impact factor: 5.952
Authors: W Lane Duvall; Joseph M Sweeny; Lori B Croft; Maya H Barghash; Nitin K Kulkarni; Krista A Guma; Milena J Henzlova Journal: J Nucl Cardiol Date: 2011-06-03 Impact factor: 5.952
Authors: Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian Journal: J Nucl Cardiol Date: 2006-11 Impact factor: 5.952
Authors: E Gordon DePuey; Srinivas Bommireddipalli; John Clark; Anna Leykekhman; Linda B Thompson; Marvin Friedman Journal: J Nucl Cardiol Date: 2011-02-02 Impact factor: 5.952
Authors: Michael Fiechter; Jelena R Ghadri; Silke M Kuest; Aju P Pazhenkottil; Mathias Wolfrum; Rene N Nkoulou; Robert Goetti; Oliver Gaemperli; Philipp A Kaufmann Journal: Eur J Nucl Med Mol Imaging Date: 2011-07-15 Impact factor: 9.236
Authors: Ryo Nakazato; Balaji K Tamarappoo; Xingping Kang; Arik Wolak; Faith Kite; Sean W Hayes; Louise E J Thomson; John D Friedman; Daniel S Berman; Piotr J Slomka Journal: J Nucl Med Date: 2010-10-18 Impact factor: 10.057
Authors: W Lane Duvall; Lori B Croft; Tapan Godiwala; Eric Ginsberg; Titus George; Milena J Henzlova Journal: J Nucl Cardiol Date: 2010-11-12 Impact factor: 5.952
Authors: Ronaldo S L Lima; Thaís R Peclat; Ana Carolina A H Souza; Aline M K Nakamoto; Felipe M Neves; Victor F Souza; Letícia B Glerian; Andrea De Lorenzo Journal: Int J Cardiovasc Imaging Date: 2017-06-29 Impact factor: 2.357
Authors: Fabio P Esteves; James R Galt; Russell D Folks; Liudmila Verdes; Ernest V Garcia Journal: J Nucl Cardiol Date: 2013-11-28 Impact factor: 5.952
Authors: Ami E Iskandrian; Vasken Dilsizian; Ernest V Garcia; Rob S Beanlands; Manuel Cerqueira; Prem Soman; Daniel S Berman; Alberto Cuocolo; Andrew J Einstein; Charity J Morgan; Fadi G Hage; Heinrich R Schelbert; Jeroen J Bax; Joseph C Wu; Leslee J Shaw; Mehran M Sadeghi; Nagara Tamaki; Philipp A Kaufmann; Robert Gropler; Sharmila Dorbala; William Van Decker Journal: J Nucl Cardiol Date: 2017-11-06 Impact factor: 5.952